Authors: MOON I KO D PROBST ST POWERS G

Citation: I. Moon et al., A SYMBOLIC MODEL VERIFIER FOR SAFE CHEMICAL PROCESS SEQUENTIAL CONTROL-SYSTEMS, Journal of Chemical Engineering of Japan, 30(1), 1997, pp. 13-22

Authors: CURTI BD OCHOA AC URBA WJ ALVORD WG KOPP WC POWERS G HAWK C CREEKMORE SP GAUSE BL JANIK JE HOLMLUND JT KREMERS P FENTON RG MILLER L SZNOL S SMITH JW SHARFMAN WH LONGO DL

Citation: Bd. Curti et al., INFLUENCE OF INTERLEUKIN-2 REGIMENS ON CIRCULATING POPULATIONS OF LYMPHOCYTES AFTER ADOPTIVE TRANSFER OF ANTI-CD3-STIMULATED T-CELLS - RESULTS FROM A PHASE-I TRIAL IN CANCER-PATIENTS, Journal of immunotherapy with emphasis on tumor immunology, 19(4), 1996, pp. 296-308

Authors: KLEMENT JF RICE NR CAR BD ABBONDANZO SJ BHATT H CHEN CH POWERS G ROSEN CA STEWART CL

Citation: Jf. Klement et al., I-KAPPA-B-ALPHA IS ESSENTIAL FOR TERMINATING NF-KAPPA-B RESPONSE AND IS CRUCIAL IN MODULATING INFLAMMATION AS ANIMALS DEFICIENT IN I-KAPPA-B-ALPHA DEVELOP A SEVERE DERMATITIS, Journal of investigative dermatology, 106(4), 1996, pp. 616-616

Authors: GREENFEDER SA VARNELL T POWERS G LOMBARDGILLOOLY K SHUSTER D MCINTYRE KW RYAN DE LEVIN W MADISON V JU G

Citation: Sa. Greenfeder et al., INSERTION OF A STRUCTURAL DOMAIN OF INTERLEUKIN (IL)-1-BETA CONFERS AGONIST ACTIVITY TO THE IL-1 RECEPTOR ANTAGONIST - IMPLICATIONS FOR IL-1 BIOACTIVITY, The Journal of biological chemistry, 270(38), 1995, pp. 22460-22466

Authors: FAHERTY D CONNAUGHTON S KOLINSKY K POWERS G NABAVI N

Citation: D. Faherty et al., ACTIVITY OF A NOVEL ANTIBODY (1G10) AGAINST THE MURINE B7 MOLECULE INCELLULAR IMMUNE-RESPONSE MODELS, The Journal of immunology, 150(8), 1993, pp. 113-113

Authors: POWERS G

Citation: G. Powers, PROFITS AT ALL COSTS, Chemical engineering, 100(9), 1993, pp. 8-8